← Open Payments lookup

CHELSEA CASTEEL: Open Payments

NPI 1619434172 · WARSAW, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$162 in 8 payments from 7 companies in 2025. Trend: 2023 $278 · 2024 $97 · 2025 $162

Food & beverage: $162
CompanyPaymentsAmount
ABBVIE INC.2$43
Dexcom, Inc.1$24
Novartis Pharmaceuticals Corporation1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20
Lilly USA, LLC1$20
Novo Nordisk Inc1$19
AstraZeneca Pharmaceuticals LP1$15

Products named: UBRELVY, Dexcom G6 Transmitter, LEQVIO, CAPLYTA, MOUNJARO, Ozempic, VRAYLAR, AIRSUPRA.

Industry payments across MO — which companies pay providers there.